Oncopeptides AB (LTS:0RN4) Accumulated Depreciation : kr0.00 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Oncopeptides AB Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Oncopeptides AB's quarterly accumulated depreciation increased from Sep. 2024 (kr0.00 Mil) to Dec. 2024 (kr-41.00 Mil) but then stayed the same from Dec. 2024 (kr-41.00 Mil) to Mar. 2025 (kr0.00 Mil).

Oncopeptides AB's annual accumulated depreciation declined from Dec. 2022 (kr-38.95 Mil) to Dec. 2023 (kr-31.22 Mil) but then increased from Dec. 2023 (kr-31.22 Mil) to Dec. 2024 (kr-41.00 Mil).

Oncopeptides AB Accumulated Depreciation Historical Data

The historical data trend for Oncopeptides AB's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncopeptides AB Accumulated Depreciation Chart

Oncopeptides AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-16.86

-33.69

-38.95

-31.22

-41.00

Oncopeptides AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-41.00	-

Oncopeptides AB Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Oncopeptides AB Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Oncopeptides AB's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncopeptides AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (LTS:0RN4) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

ONCO:Sweden OND:Germany

Address

Luntmakargatan 46, Stockholm, SWE, SE-111 37

Website

https://www.oncopeptides.com

Oncopeptides AB is a biotech company focused on the research, development, and commercialization of therapies for difficult-to-treat hematological diseases. The company uses its proprietary Peptide Drug Conjugate (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. It has focused on the development of the product candidate Melflufen (Pepaxti), a peptide-conjugated alkylator, belonging to a new class of drugs called Peptidase Enhanced Compounds. Melflufen is intended as an effective treatment for hematological cancers and, in particular, multiple myeloma.

Oncopeptides AB Headlines

No Headlines